Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Eiichi Watanabe

Showing results (131-140 of 142) with videos related to

Pageof 15
Sort By:
Circulation Journal : Official Journal of the Japanese Circulation Society|June 3, 2016
Regional Differences in Frequency of Warfarin Therapy and Thromboembolism in Japanese Patients With Non-Valvular Atrial Fibrillation　- Analysis of the J-RHYTHM RegistryHiroshi Inoue, Hirotsugu Atarashi, Eitaro Kodani, et al.
The American Journal of Cardiology|January 28, 2014
Impact of gender on the prognosis of patients with nonvalvular atrial fibrillationHiroshi Inoue, Hirotsugu Atarashi, Ken Okumura, et al.
Nagoya Journal of Medical Science|December 17, 2021
＜Editors' Choice＞ Prevalence of acute coronary syndrome during the pandemic of COVID-19 in the Tokai Region of JapanNobutaka Kudo, Akihito Tanaka, Hideki Ishii, et al.
Circulation|January 28, 2014
Variations in cause and management of atrial fibrillation in a prospective registry of 15,400 emergency department patients in 46 countries: the RE-LY Atrial Fibrillation RegistryJonas Oldgren, Jeff S Healey, Michael Ezekowitz, et al.
Europace : European Pacing, Arrhythmias, and Cardiac Electrophysiology : Journal of the Working Groups on Cardiac Pacing, Arrhythmias, and Cardiac Cellular Electrophysiology of the European Society of Cardiology|December 15, 2010
Randomized trial of angiotensin II-receptor blocker vs. dihydropiridine calcium channel blocker in the treatment of paroxysmal atrial fibrillation with hypertension (J-RHYTHM II study)Takeshi Yamashita, Hiroshi Inoue, Ken Okumura, et al.
Thrombosis Research|June 21, 2015
Non-valvular atrial fibrillation patients with low CHADS2 scores benefit from warfarin therapy according to propensity score matching subanalysis using the J-RHYTHM RegistryAkiko Chishaki, Naoko Kumagai, Naohiko Takahashi, et al.
Journal of the American Heart Association|October 25, 2024
Global Results of Implantable Loop Recorder for Detection of Atrial Fibrillation After Stroke: Reveal LINQ RegistryKazunori Toyoda, Kengo Kusano, Yasuyuki Iguchi, et al.
Journal of Thrombosis and Thrombolysis|April 8, 2019
Clinical experience of idarucizumab use in cases of cardiac tamponade under uninterrupted anticoagulation of dabigatran during catheter ablation of atrial fibrillationKaoru Okishige, Yasuteru Yamauchi, Yuichi Hanaki, et al.
Circulation. Arrhythmia and Electrophysiology|October 22, 2009
Latent genetic backgrounds and molecular pathogenesis in drug-induced long-QT syndromeHideki Itoh, Tomoko Sakaguchi, Wei-Guang Ding, et al.
Journal of Atherosclerosis and Thrombosis|December 9, 2021
Small Dense Low-Density Lipoprotein Cholesterol and Cardiovascular Risk in Statin-Treated Patients with Coronary Artery DiseaseJunnichi Ishii, Kosuke Kashiwabara, Yukio Ozaki, et al.
Pageof 15

Showing results (131-140 of 142) with videos related to

Sort By:
Pageof 15
Circulation Journal : Official Journal of the Japanese Circulation Society|June 3, 2016
Regional Differences in Frequency of Warfarin Therapy and Thromboembolism in Japanese Patients With Non-Valvular Atrial Fibrillation　- Analysis of the J-RHYTHM RegistryHiroshi Inoue, Hirotsugu Atarashi, Eitaro Kodani, et al.
The American Journal of Cardiology|January 28, 2014
Impact of gender on the prognosis of patients with nonvalvular atrial fibrillationHiroshi Inoue, Hirotsugu Atarashi, Ken Okumura, et al.
Nagoya Journal of Medical Science|December 17, 2021
＜Editors' Choice＞ Prevalence of acute coronary syndrome during the pandemic of COVID-19 in the Tokai Region of JapanNobutaka Kudo, Akihito Tanaka, Hideki Ishii, et al.
Circulation|January 28, 2014
Variations in cause and management of atrial fibrillation in a prospective registry of 15,400 emergency department patients in 46 countries: the RE-LY Atrial Fibrillation RegistryJonas Oldgren, Jeff S Healey, Michael Ezekowitz, et al.
Europace : European Pacing, Arrhythmias, and Cardiac Electrophysiology : Journal of the Working Groups on Cardiac Pacing, Arrhythmias, and Cardiac Cellular Electrophysiology of the European Society of Cardiology|December 15, 2010
Randomized trial of angiotensin II-receptor blocker vs. dihydropiridine calcium channel blocker in the treatment of paroxysmal atrial fibrillation with hypertension (J-RHYTHM II study)Takeshi Yamashita, Hiroshi Inoue, Ken Okumura, et al.
Thrombosis Research|June 21, 2015
Non-valvular atrial fibrillation patients with low CHADS2 scores benefit from warfarin therapy according to propensity score matching subanalysis using the J-RHYTHM RegistryAkiko Chishaki, Naoko Kumagai, Naohiko Takahashi, et al.
Journal of the American Heart Association|October 25, 2024
Global Results of Implantable Loop Recorder for Detection of Atrial Fibrillation After Stroke: Reveal LINQ RegistryKazunori Toyoda, Kengo Kusano, Yasuyuki Iguchi, et al.
Journal of Thrombosis and Thrombolysis|April 8, 2019
Clinical experience of idarucizumab use in cases of cardiac tamponade under uninterrupted anticoagulation of dabigatran during catheter ablation of atrial fibrillationKaoru Okishige, Yasuteru Yamauchi, Yuichi Hanaki, et al.
Circulation. Arrhythmia and Electrophysiology|October 22, 2009
Latent genetic backgrounds and molecular pathogenesis in drug-induced long-QT syndromeHideki Itoh, Tomoko Sakaguchi, Wei-Guang Ding, et al.
Journal of Atherosclerosis and Thrombosis|December 9, 2021
Small Dense Low-Density Lipoprotein Cholesterol and Cardiovascular Risk in Statin-Treated Patients with Coronary Artery DiseaseJunnichi Ishii, Kosuke Kashiwabara, Yukio Ozaki, et al.
Pageof 15